Branched‐chain amino acids improve insulin resistance in patients with hepatitis C virus‐related liver disease: report of two cases

Hepatitis C virus (HCV) infection causes insulin resistance. Because increased insulin resistance is a risk factor for development of hepatocellular carcinoma and reduced long‐term survival, insulin resistance is a therapeutic target in patients with HCV infection. Branched‐chain amino acids (BCAAs)...

Full description

Saved in:
Bibliographic Details
Published in:Liver international 2007-11, Vol.27 (9), p.1287-1292
Main Authors: Kawaguchi, Takumi, Taniguchi, Eitaro, Itou, Minoru, Sumie, Shuji, Oriishi, Tetsuharu, Matsuoka, Hisako, Nagao, Yumiko, Sata, Michio
Format: Article
Language:English
Subjects:
Aged
Amino Acids, Branched-Chain - therapeutic use
branched‐chain amino acids
Female
Hepacivirus - pathogenicity
Hepatitis C - drug therapy
Hepatitis C - virology
Hepatitis C virus
Humans
Insulin Resistance
lipid metabolism
nutritional support
protein‐energy malnutrition
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4489-9a1642efcd9c0c5d6e1e69703743738e46d789e7e084f8a8c316667794b4f5fd3
cites cdi_FETCH-LOGICAL-c4489-9a1642efcd9c0c5d6e1e69703743738e46d789e7e084f8a8c316667794b4f5fd3
container_end_page 1292
container_issue 9
container_start_page 1287
container_title Liver international
container_volume 27
creator Kawaguchi, Takumi
Taniguchi, Eitaro
Itou, Minoru
Sumie, Shuji
Oriishi, Tetsuharu
Matsuoka, Hisako
Nagao, Yumiko
Sata, Michio
description Hepatitis C virus (HCV) infection causes insulin resistance. Because increased insulin resistance is a risk factor for development of hepatocellular carcinoma and reduced long‐term survival, insulin resistance is a therapeutic target in patients with HCV infection. Branched‐chain amino acids (BCAAs) are not only structural constituents of proteins but they are also considered as regulators of insulin signalling. We first describe two cases suggesting that administration of BCAAs improves insulin resistance associated with HCV‐related liver disease. Although there were no changes in body weight, plasma glucose concentration and haemoglobin A1c (HbA1c) value were decreased. Moreover, BCAAs caused a decrease in both fasting insulin concentration and the value of homeostasis model assessment for insulin resistance. Thus, BCAAs are a potential therapeutic agent for improving insulin resistance in patients with HCV‐related liver disease.
doi_str_mv 10.1111/j.1478-3231.2007.01559.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68357781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68357781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4489-9a1642efcd9c0c5d6e1e69703743738e46d789e7e084f8a8c316667794b4f5fd3</originalsourceid><addsrcrecordid>eNqNkbuOEzEUhkcIxC4Lr4Bc0WWwxx5fkCgg4rJSJBqgtbz2GcXRXIKPJ9nt6Gh5Rp4ED4mWEtz4XP7_t6yvqgijNSvn5a5mQukVbzirG0pVTVnbmvr2QXV5v3h4Xzf8onqCuKOUGdOyx9UFU4aZRjSX1Y-3yY1-C-HX959-6-JI3BDHiTgfA5I47NN0ABJHnPuyS4ARczEsI7J3OcKYkRxj3pItLH2OSNbkENOMJTFB7zIE0scDJBIigkN4VWL2U8pk6kg-TsSXGT6tHnWuR3h2vq-qL-_ffV5_XG0-fbhev9msvBDarIxjUjTQ-WA89W2QwEAaRbkSXHENQgalDSigWnTaac-ZlFIpI25E13aBX1UvTrnlY99mwGyHiB763o0wzWil5q1Smv1T2FBtuJC0CPVJ6NOEmKCz-xQHl-4so3ahZXd2AWEXKHahZf_QsrfF-vz8xnwzQPhrPOMpgtcnwTH2cPffwXZz_XWp-G-DJ6c1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20893460</pqid></control><display><type>article</type><title>Branched‐chain amino acids improve insulin resistance in patients with hepatitis C virus‐related liver disease: report of two cases</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Itou, Minoru ; Sumie, Shuji ; Oriishi, Tetsuharu ; Matsuoka, Hisako ; Nagao, Yumiko ; Sata, Michio</creator><creatorcontrib>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Itou, Minoru ; Sumie, Shuji ; Oriishi, Tetsuharu ; Matsuoka, Hisako ; Nagao, Yumiko ; Sata, Michio</creatorcontrib><description>Hepatitis C virus (HCV) infection causes insulin resistance. Because increased insulin resistance is a risk factor for development of hepatocellular carcinoma and reduced long‐term survival, insulin resistance is a therapeutic target in patients with HCV infection. Branched‐chain amino acids (BCAAs) are not only structural constituents of proteins but they are also considered as regulators of insulin signalling. We first describe two cases suggesting that administration of BCAAs improves insulin resistance associated with HCV‐related liver disease. Although there were no changes in body weight, plasma glucose concentration and haemoglobin A1c (HbA1c) value were decreased. Moreover, BCAAs caused a decrease in both fasting insulin concentration and the value of homeostasis model assessment for insulin resistance. Thus, BCAAs are a potential therapeutic agent for improving insulin resistance in patients with HCV‐related liver disease.</description><identifier>ISSN: 1478-3223</identifier><identifier>EISSN: 1478-3231</identifier><identifier>EISSN: 1399-1698</identifier><identifier>DOI: 10.1111/j.1478-3231.2007.01559.x</identifier><identifier>PMID: 17919242</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Amino Acids, Branched-Chain - therapeutic use ; branched‐chain amino acids ; Female ; Hepacivirus - pathogenicity ; Hepatitis C - drug therapy ; Hepatitis C - virology ; Hepatitis C virus ; Humans ; Insulin Resistance ; lipid metabolism ; nutritional support ; protein‐energy malnutrition ; Treatment Outcome</subject><ispartof>Liver international, 2007-11, Vol.27 (9), p.1287-1292</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4489-9a1642efcd9c0c5d6e1e69703743738e46d789e7e084f8a8c316667794b4f5fd3</citedby><cites>FETCH-LOGICAL-c4489-9a1642efcd9c0c5d6e1e69703743738e46d789e7e084f8a8c316667794b4f5fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17919242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawaguchi, Takumi</creatorcontrib><creatorcontrib>Taniguchi, Eitaro</creatorcontrib><creatorcontrib>Itou, Minoru</creatorcontrib><creatorcontrib>Sumie, Shuji</creatorcontrib><creatorcontrib>Oriishi, Tetsuharu</creatorcontrib><creatorcontrib>Matsuoka, Hisako</creatorcontrib><creatorcontrib>Nagao, Yumiko</creatorcontrib><creatorcontrib>Sata, Michio</creatorcontrib><title>Branched‐chain amino acids improve insulin resistance in patients with hepatitis C virus‐related liver disease: report of two cases</title><title>Liver international</title><addtitle>Liver Int</addtitle><description>Hepatitis C virus (HCV) infection causes insulin resistance. Because increased insulin resistance is a risk factor for development of hepatocellular carcinoma and reduced long‐term survival, insulin resistance is a therapeutic target in patients with HCV infection. Branched‐chain amino acids (BCAAs) are not only structural constituents of proteins but they are also considered as regulators of insulin signalling. We first describe two cases suggesting that administration of BCAAs improves insulin resistance associated with HCV‐related liver disease. Although there were no changes in body weight, plasma glucose concentration and haemoglobin A1c (HbA1c) value were decreased. Moreover, BCAAs caused a decrease in both fasting insulin concentration and the value of homeostasis model assessment for insulin resistance. Thus, BCAAs are a potential therapeutic agent for improving insulin resistance in patients with HCV‐related liver disease.</description><subject>Aged</subject><subject>Amino Acids, Branched-Chain - therapeutic use</subject><subject>branched‐chain amino acids</subject><subject>Female</subject><subject>Hepacivirus - pathogenicity</subject><subject>Hepatitis C - drug therapy</subject><subject>Hepatitis C - virology</subject><subject>Hepatitis C virus</subject><subject>Humans</subject><subject>Insulin Resistance</subject><subject>lipid metabolism</subject><subject>nutritional support</subject><subject>protein‐energy malnutrition</subject><subject>Treatment Outcome</subject><issn>1478-3223</issn><issn>1478-3231</issn><issn>1399-1698</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNkbuOEzEUhkcIxC4Lr4Bc0WWwxx5fkCgg4rJSJBqgtbz2GcXRXIKPJ9nt6Gh5Rp4ED4mWEtz4XP7_t6yvqgijNSvn5a5mQukVbzirG0pVTVnbmvr2QXV5v3h4Xzf8onqCuKOUGdOyx9UFU4aZRjSX1Y-3yY1-C-HX959-6-JI3BDHiTgfA5I47NN0ABJHnPuyS4ARczEsI7J3OcKYkRxj3pItLH2OSNbkENOMJTFB7zIE0scDJBIigkN4VWL2U8pk6kg-TsSXGT6tHnWuR3h2vq-qL-_ffV5_XG0-fbhev9msvBDarIxjUjTQ-WA89W2QwEAaRbkSXHENQgalDSigWnTaac-ZlFIpI25E13aBX1UvTrnlY99mwGyHiB763o0wzWil5q1Smv1T2FBtuJC0CPVJ6NOEmKCz-xQHl-4so3ahZXd2AWEXKHahZf_QsrfF-vz8xnwzQPhrPOMpgtcnwTH2cPffwXZz_XWp-G-DJ6c1</recordid><startdate>200711</startdate><enddate>200711</enddate><creator>Kawaguchi, Takumi</creator><creator>Taniguchi, Eitaro</creator><creator>Itou, Minoru</creator><creator>Sumie, Shuji</creator><creator>Oriishi, Tetsuharu</creator><creator>Matsuoka, Hisako</creator><creator>Nagao, Yumiko</creator><creator>Sata, Michio</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200711</creationdate><title>Branched‐chain amino acids improve insulin resistance in patients with hepatitis C virus‐related liver disease: report of two cases</title><author>Kawaguchi, Takumi ; Taniguchi, Eitaro ; Itou, Minoru ; Sumie, Shuji ; Oriishi, Tetsuharu ; Matsuoka, Hisako ; Nagao, Yumiko ; Sata, Michio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4489-9a1642efcd9c0c5d6e1e69703743738e46d789e7e084f8a8c316667794b4f5fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Amino Acids, Branched-Chain - therapeutic use</topic><topic>branched‐chain amino acids</topic><topic>Female</topic><topic>Hepacivirus - pathogenicity</topic><topic>Hepatitis C - drug therapy</topic><topic>Hepatitis C - virology</topic><topic>Hepatitis C virus</topic><topic>Humans</topic><topic>Insulin Resistance</topic><topic>lipid metabolism</topic><topic>nutritional support</topic><topic>protein‐energy malnutrition</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawaguchi, Takumi</creatorcontrib><creatorcontrib>Taniguchi, Eitaro</creatorcontrib><creatorcontrib>Itou, Minoru</creatorcontrib><creatorcontrib>Sumie, Shuji</creatorcontrib><creatorcontrib>Oriishi, Tetsuharu</creatorcontrib><creatorcontrib>Matsuoka, Hisako</creatorcontrib><creatorcontrib>Nagao, Yumiko</creatorcontrib><creatorcontrib>Sata, Michio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Liver international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawaguchi, Takumi</au><au>Taniguchi, Eitaro</au><au>Itou, Minoru</au><au>Sumie, Shuji</au><au>Oriishi, Tetsuharu</au><au>Matsuoka, Hisako</au><au>Nagao, Yumiko</au><au>Sata, Michio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Branched‐chain amino acids improve insulin resistance in patients with hepatitis C virus‐related liver disease: report of two cases</atitle><jtitle>Liver international</jtitle><addtitle>Liver Int</addtitle><date>2007-11</date><risdate>2007</risdate><volume>27</volume><issue>9</issue><spage>1287</spage><epage>1292</epage><pages>1287-1292</pages><issn>1478-3223</issn><eissn>1478-3231</eissn><eissn>1399-1698</eissn><abstract>Hepatitis C virus (HCV) infection causes insulin resistance. Because increased insulin resistance is a risk factor for development of hepatocellular carcinoma and reduced long‐term survival, insulin resistance is a therapeutic target in patients with HCV infection. Branched‐chain amino acids (BCAAs) are not only structural constituents of proteins but they are also considered as regulators of insulin signalling. We first describe two cases suggesting that administration of BCAAs improves insulin resistance associated with HCV‐related liver disease. Although there were no changes in body weight, plasma glucose concentration and haemoglobin A1c (HbA1c) value were decreased. Moreover, BCAAs caused a decrease in both fasting insulin concentration and the value of homeostasis model assessment for insulin resistance. Thus, BCAAs are a potential therapeutic agent for improving insulin resistance in patients with HCV‐related liver disease.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17919242</pmid><doi>10.1111/j.1478-3231.2007.01559.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1478-3223
ispartof Liver international, 2007-11, Vol.27 (9), p.1287-1292
issn 1478-3223
1478-3231
1399-1698
language eng
recordid cdi_proquest_miscellaneous_68357781
source Wiley-Blackwell Read & Publish Collection
subjects Aged
Amino Acids, Branched-Chain - therapeutic use
branched‐chain amino acids
Female
Hepacivirus - pathogenicity
Hepatitis C - drug therapy
Hepatitis C - virology
Hepatitis C virus
Humans
Insulin Resistance
lipid metabolism
nutritional support
protein‐energy malnutrition
Treatment Outcome
title Branched‐chain amino acids improve insulin resistance in patients with hepatitis C virus‐related liver disease: report of two cases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A56%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Branched%E2%80%90chain%20amino%20acids%20improve%20insulin%20resistance%20in%20patients%20with%20hepatitis%20C%20virus%E2%80%90related%20liver%20disease:%20report%20of%20two%20cases&rft.jtitle=Liver%20international&rft.au=Kawaguchi,%20Takumi&rft.date=2007-11&rft.volume=27&rft.issue=9&rft.spage=1287&rft.epage=1292&rft.pages=1287-1292&rft.issn=1478-3223&rft.eissn=1478-3231&rft_id=info:doi/10.1111/j.1478-3231.2007.01559.x&rft_dat=%3Cproquest_cross%3E68357781%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4489-9a1642efcd9c0c5d6e1e69703743738e46d789e7e084f8a8c316667794b4f5fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20893460&rft_id=info:pmid/17919242&rfr_iscdi=true